48 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
, before expenses, to us
Underwriting discounts and commissions do not include the reimbursement of certain expenses of the underwriter we have agreed
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
and commissions do not include the reimbursement of certain expenses of the underwriter we have agreed to pay. See “Underwriting” for a description
8-K
EX-10.1
zqa28btv
1 May 23
Departure of Directors or Certain Officers
7:30am
S-3
fas04u4uc ht
23 Dec 22
Shelf registration
4:16pm
8-K
EX-1.1
m3t5e3
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
hm74zayieay0hf
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
7azber
20 Oct 22
Draft registration statement
12:00am